These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28566054)

  • 1. Biologics for psoriasis : maintenance treatment and true disease modification.
    van de Kerkhof PC
    J Dermatolog Treat; 2017 Jun; 28(4):281. PubMed ID: 28566054
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of biologics for psoriasis in Central and Eastern European countries.
    Rencz F; Kemény L; Gajdácsi JZ; Owczarek W; Arenberger P; Tiplica GS; Stanimirović A; Niewada M; Petrova G; Marinov LT; Kazandhieva J; Péntek M; Brodszky V; Gulácsi L
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2222-30. PubMed ID: 26370506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare Provider Type and Switch to Biologics in Psoriasis: Evidence from Real-World Practice.
    Calara PS; Norlin JM; Althin R; Carlsson KS; Schmitt-Egenolf M
    BioDrugs; 2016 Apr; 30(2):145-51. PubMed ID: 26883786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug survival is not significantly different between biologics in patients with psoriasis vulgaris: a single-centre database analysis.
    Menting SP; Sitaram AS; Bonnerjee-van der Stok HM; de Rie MA; Hooft L; Spuls PI
    Br J Dermatol; 2014 Oct; 171(4):875-83. PubMed ID: 24673245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Register-Based Evaluation of Relative Effectiveness of New Therapies: Biologics Versus Conventional Agents in Treatment of Psoriasis in Sweden.
    Norlin JM; Carlsson KS; Persson U; Schmitt-Egenolf M
    BioDrugs; 2015 Dec; 29(6):389-98. PubMed ID: 26670179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Japanese guidance for use of biologics for psoriasis (the 2013 version).
    Ohtsuki M; Terui T; Ozawa A; Morita A; Sano S; Takahashi H; Komine M; Etoh T; Igarashi A; Torii H; Asahina A; Nemoto O; Nakagawa H;
    J Dermatol; 2013 Sep; 40(9):683-95. PubMed ID: 24033880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of biologics versus conventional systemic therapies in the treatment of psoriasis at a comprehensive psoriasis care center.
    Au SC; Madani A; Alhaddad M; Alkofide M; Gottlieb AB
    J Drugs Dermatol; 2013 Aug; 12(8):861-6. PubMed ID: 23986158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of psoriasis drug failure rates and reasons for discontinuation in biologics vs conventional systemic therapies.
    Levin AA; Gottlieb AB; Au SC
    J Drugs Dermatol; 2014 Jul; 13(7):848-53. PubMed ID: 25007369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Satisfaction of treatment with biologics is high in psoriasis: results from the Bio-CAPTURE network.
    van den Reek JM; van Lüumig PP; Otero ME; Zweegers J; van de Kerkhof PC; Ossenkoppele PM; Njoo MD; Mommers JM; Koetsier MI; Arnold WP; Sybrandy-Fleuren BA; Kuijpers AL; Andriessen MP; Seyger MM; Kievit W; de Jong EM
    Br J Dermatol; 2014 May; 170(5):1158-65. PubMed ID: 24484403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasis.
    Bhosle MJ; Feldman SR; Camacho FT; Timothy Whitmire J; Nahata MC; Balkrishnan R
    J Dermatolog Treat; 2006; 17(5):294-301. PubMed ID: 17092860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing treatment goals for psoriasis with treatment decisions in daily practice: results from a prospective cohort of patients with psoriasis treated with biologics: BioCAPTURE.
    Zweegers J; van den Reek JM; van de Kerkhof PC; Otero ME; Ossenkoppele PM; Njoo MD; Mommers JM; Koetsier MI; Arnold WP; Sybrandy-Fleuren BA; Kuijpers AL; Andriessen MP; Kievit W; de Jong EM
    Br J Dermatol; 2014 Nov; 171(5):1091-8. PubMed ID: 24861358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patch test results in psoriasis patients on biologics.
    Kim N; Notik S; Gottlieb AB; Scheinman PL
    Dermatitis; 2014; 25(4):182-90. PubMed ID: 25000235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs of therapy with biologics in the treatment of moderate to severe plaque psoriasis in the context of the Italian health-care system.
    Terranova L; Mattozzi C; Richetta AG; Mantuano M; Cardosi L; Teruzzi C
    G Ital Dermatol Venereol; 2014 Feb; 149(1):131-43. PubMed ID: 24566574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of moderate to severe plaque psoriasis with biologics: analysis of the additional cost of temporary dose escalation vs switch to another biologic after failure of maintenance therapy.
    Puig L
    Actas Dermosifiliogr; 2014 May; 105(4):401-12. PubMed ID: 24444743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
    Garber C; Plotnikova N; Au SC; Sorensen EP; Gottlieb A
    J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
    Tzu J; Kerdel F
    Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of malignancy or progression of existing malignancy in patients with psoriasis treated with biologics: case report and review of the literature.
    Patel S; Patel T; Kerdel FA
    Int J Dermatol; 2016 May; 55(5):487-93. PubMed ID: 26711080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of psoriatic disease and current treatment patterns from 2003 to 2013: A nationwide, population-based observational study in Taiwan.
    Wang TS; Hsieh CF; Tsai TF
    J Dermatol Sci; 2016 Dec; 84(3):340-345. PubMed ID: 27576765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of biologics in erythrodermic psoriasis: a multicentre, retrospective study.
    Viguier M; Pagès C; Aubin F; Delaporte E; Descamps V; Lok C; Beylot-Barry M; Séneschal J; Dubertret L; Morand JJ; Dréno B; Bachelez H;
    Br J Dermatol; 2012 Aug; 167(2):417-23. PubMed ID: 22413927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry.
    Inzinger M; Heschl B; Weger W; Hofer A; Legat FJ; Gruber-Wackernagel A; Tilz H; Salmhofer W; Quehenberger F; Wolf P
    Br J Dermatol; 2011 Sep; 165(3):640-5. PubMed ID: 21564068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.